Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Glenzocimab

Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.

Product Specifications

CAS Number

2101829-58-5

Stability

≥ 2 years

Purity

>98% (HPLC)

Molecular Formula

——

Notes

Research use only, not for human use.

Receptor

Others

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Cynomolgus Monkey Recombinant Lgr4/GPR48 Protein
NHFF-0524-HX391 Each

Cynomolgus Monkey Recombinant Lgr4/GPR48 Protein

Sign In for Pricing
View Details
RGD1562392 3'UTR Luciferase Stable Cell Line
TU218567 1.0 mL

RGD1562392 3'UTR Luciferase Stable Cell Line

Sign In for Pricing
View Details
2-Ethynyl-1-methyl-1H-1,3-benzodiazole
HBA54501-01 50 mg

2-Ethynyl-1-methyl-1H-1,3-benzodiazole

Sign In for Pricing
View Details
2-Ethynyl-1-methyl-1H-1,3-benzodiazole
HBA54501-02 0.5 g

2-Ethynyl-1-methyl-1H-1,3-benzodiazole

Sign In for Pricing
View Details
Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)
TRV-0032546-01 20 µL

Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)

Sign In for Pricing
View Details
Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)
TRV-0032546-02 100 µL

Monoclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)

Sign In for Pricing
View Details